Crescent Biopharma (CBIO) Share-based Compensation Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 20.65% |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | 67.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.82% |
| Dec 31, 2025 | 74.10% |
| Sep 30, 2025 | 29.52% |
| Jun 30, 2025 | 76.95% |
| Mar 31, 2025 | 4.38% |
| Dec 31, 2024 | -4.94% |
| Sep 30, 2024 | -64.87% |
| Jun 30, 2024 | -8.23% |
| Mar 31, 2024 | -9.61% |
| Dec 31, 2023 | -17.67% |
| Sep 30, 2023 | -19.32% |
| Jun 30, 2023 | -21.32% |
| Mar 31, 2023 | -21.84% |
| Dec 31, 2022 | -19.54% |
| Sep 30, 2022 | -16.80% |
| Jun 30, 2022 | -14.08% |
| Mar 31, 2022 | -7.88% |
| Dec 31, 2021 | 4.71% |
| Sep 30, 2021 | 10.75% |
| Jun 30, 2021 | 10.74% |
| Mar 31, 2021 | 13.10% |
| Dec 31, 2020 | 19.05% |
| Sep 30, 2020 | 20.66% |
| Jun 30, 2020 | 21.13% |
| Mar 31, 2020 | 29.30% |
| Dec 31, 2019 | 33.46% |
| Sep 30, 2019 | 29.00% |
| Jun 30, 2019 | 25.34% |
| Mar 31, 2019 | 23.86% |
| Dec 31, 2018 | 21.25% |
| Sep 30, 2018 | 22.77% |
| Jun 30, 2018 | 35.91% |
| Mar 31, 2018 | 23.84% |
| Dec 31, 2017 | 25.96% |
| Sep 30, 2017 | 29.63% |
| Jun 30, 2017 | 33.30% |
| Mar 31, 2017 | 42.35% |
| Dec 31, 2016 | 128.82% |
| Sep 30, 2016 | 71.18% |
| Jun 30, 2016 | 91.63% |
| Mar 31, 2016 | 88.86% |